Home/Filings/3/0001493152-26-000375
3//SEC Filing

Injective Foundation 3

Accession 0001493152-26-000375

CIK 0001938109other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:05 PM ET

Size

4.6 KB

Accession

0001493152-26-000375

Insider Transaction Report

Form 3
Period: 2025-12-30
Holdings
  • Common Shares

    9,615,385
Footnotes (1)
  • [F1]The securities reported are held directly by Injective Foundation and may be deemed to be beneficially owned by Glenn Kennedy because Mr. Kennedy, as director of Injective Foundation, has investment and dispositive control of the securities. Mr. Kennedy disclaims beneficial ownership of these securities, has no pecuniary interest in the securities reported, and this form shall not be construed as an admission that he is the beneficial owner of any of the securities reported on this form.

Documents

1 file

Issuer

Pineapple Financial Inc.

CIK 0001938109

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0002094853

Filing Metadata

Form type
3
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:05 PM ET
Size
4.6 KB